APASL 2025 Expert Interview | Prof. George Lau: Dilemmas and Breakthroughs in Clinical Cure of Chronic Hepatitis B and Liver Cancer Prevention
At the 34th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2025), Professor George Lau, Chairman of Hong Kong Humanity Medical Group and Director of Humanity Medical Clinical Research Center, shared important insights on cuttingedge topics including clinical cure of chronic hepatitis B (CHB) and liver cancer prevention. With the WHO’s 2030 goal to eliminate CHB approaching, China’s CHB prevention and treatment efforts face new opportunities and challenges. In this exclusive interview, drawing on his extensive clinical experience, Professor Lau systematically outlines key breakthroughs and remaining dilemmas in the fields of CHB clinical cure and liver cancer prevention, offering valuable professional perspectives to advance China’s work in CHB and liver cancer control.
ILCA Roundtable | MDT: Optimizing HCC Treatment Strategies – Insights from the TALENT Series Studies
In recent years, advances in systemic therapy have offered hope for advanced liver cancer patients, but traditional single treatments remain limited, highlighting the need for new approaches. Combining systemic therapy with local treatments has become a key trend, with multidisciplinary team (MDT) collaboration now a global standard. Experts from surgery, interventional radiology, oncology, and more work together to design optimal, personalized treatment plans—from diagnosis and strategy development to timing of therapy and long-term follow-up.
West China UroOncology Tianfu Conference丨Professor Wei Xue Shares the Renji Experience in Comprehensive Prostate Cancer Management
Editor’s Note: Prostate cancer is one of the most common malignant tumors of the male genitourinary system. Exploring innovative diagnostic and treatment strategies and promoting standardized whole-course management may further improve…
Prof. Raynier Devillier: Three Key Focuses in HSCT for the Elderly—Disease Status, Conditioning Intensity, and Donor Selection
With the aging population, the demand for hematopoietic stem cell transplantation (HSCT) among elderly patients with hematologic malignancies is growing, yet clinical decision-making faces increasingly complex challenges. In the process…
Professor Alejandro Madrigal: The Path to Breakthrough for the Localization of CAR-T Cell Therapy in Latin America
In the global wave of medical innovation, emerging therapies such as CAR-T cell therapy have brought revolutionary hope for
major diseases, including malignancies. However, their widespread adoption and application face significant regional imbalances, with low- and middle-income countries encountering numerous structural barriers in accessing these frontier technologies. From November 13 to 16, 2025, the 2025 International Conference on Cell and Immunotherapy (CTI 2025) was held in Hangzhou, Zhejiang. During the conference, Oncology Frontier - Hematology specially invited Professor Alejandro Madrigal from University College London (UCL) to discuss, from an international perspective and using Mexico as a case study, the core challenges Latin America faces in promoting equitable access to medical resources and introducing cutting-edge therapies.
CCHIO 2025丨Guojun Zhang: A Landmark Event in Spring City Advancing Integrated Oncology Prevention and Treatment
Editor’s Note: The 2025 China Conference on Holistic and Integrative Oncology (CCHIO) was held in Kunming from November 6–9, 2025. The meeting was hosted by the China Anti-Cancer Association (CACA)…
2025 CCHIO | Prof. Chen Xiaobing: Winning the Fight Against Cancer Through Integrated, Comprehensive Practice
Editor’s Note: In cancer prevention and treatment, integrative medicine is not merely a technical convergence but a human-centered medical philosophy. It breaks traditional disciplinary boundaries and weaves prevention, treatment, and…
2025 CCHIO | Professor Han Guohong: Clinical Application Strategies of Yttrium-90 Under the 2025 BCLC Framework
Editor’s Note: The updated 2025 Barcelona Clinic Liver Cancer (BCLC) staging and treatment guidelines—an international authority in hepatology—were recently released. While maintaining its traditional staging structure, the new version further…
2025 CCHIO | CACA Signs Memoranda of Understanding with Four Major International Organizations, Expanding Global Collaboration
Editor’s Note: On November 8, 2025, during the China Conference on Holistic and Integrative Oncology (CCHIO), the China Anti-Cancer Association (CACA) held a grand signing ceremony for Memoranda of Understanding…